Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bone Biologics CorpBBLG · Entity 8560 | Director · Chairman of the Board · 10% owner | March 27, 2023 | March 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bone Biologics Corp
Report date March 27, 2023 · Filed March 29, 2023
Jointly reported with Knight Insurance Company, Ltd
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Hankey Capital, LLC | 0 |
Reported balance
After 2023-03-13 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-03-13 · Other · Disposed 500,137 · Balance 0 F1: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.30 · Expires 2026-10-13 | IndirectHankey Capital, LLC | 0 |
Reported balance
After 2023-03-13 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-03-13 · Other · Disposed 33,811 · Balance 0 F1: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.30 · Expires 2026-10-13 | IndirectDon Hankey Trust | 280,764 |
Reported balance
After 2023-03-13 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-03-13 · Other · Acquired 280,764 · Balance 280,764 F1: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.30 · Expires 2026-10-13 | IndirectKnight Services, Inc | 5,252 |
Reported balance
After 2023-03-13 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-03-13 · Other · Acquired 5,252 · Balance 5,252 F1: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.30 · Expires 2026-10-13 | IndirectKnight Insurance Company, Ltd. | 99,148 |
Reported balance
After 2023-03-13 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2023-03-13 · Other · Acquired 99,148 · Balance 99,148 F1: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.30 · Expires 2026-10-13 | IndirectKnightbrook Insurance Company | 19,297 |
Reported balance
After 2023-03-13 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2023-03-13 · Other · Acquired 19,297 · Balance 19,297 F1: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.30 · Expires 2026-10-13 | IndirectKnight Specialty Insurance Company | 37,918 |
Reported balance
After 2023-03-13 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2023-03-13 · Other · Acquired 37,918 · Balance 37,918 F1: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants |
| Common StockSEC Table I · non-derivative | IndirectKnight Services, Inc | 77,681 |
Reported balance
Holding disclosure · report date 2023-03-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 77,681 |
| Common StockSEC Table I · non-derivative | IndirectKnight Insurance Company, Ltd. | 1,466,603 |
Reported balance
Holding disclosure · report date 2023-03-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,466,603 |
| Common StockSEC Table I · non-derivative | IndirectKnightbrook Insurance Company | 285,438 |
Reported balance
Holding disclosure · report date 2023-03-27 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 285,438 |
| Common StockSEC Table I · non-derivative | IndirectKnight Specialty Insurance Company | 560,877 |
Reported balance
Holding disclosure · report date 2023-03-27 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 560,877 |
| Common StockSEC Table I · non-derivative | IndirectDon Hankey Trust | 4,279,721 |
Reported balance
Holding disclosure · report date 2023-03-27 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 4,279,721 |
| Common StockSEC Table I · non-derivative | IndirectH&H Funding LLC | 31,696 |
Reported balance
Holding disclosure · report date 2023-03-27 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 31,696 |
Filing footnotes · ownership attribution and instrument terms
F1: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2023 Filed Mar 29, 2023 16:55 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherWarrants to Purchase Common Stock · Derivative | 37,918 | $0.01 Strike: $6.30 | $379.18 |
DisclosureSEC source: 0001493152-23-009491 · ownership.xml · derivative · entry 13 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner Knight Insurance Company, Ltd · CIK 0001971547 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Knight Specialty Insurance Company Disclosed balance after: 37,918 Underlying: Common · 37,918 shares Expires 2026-10-13 F1 · kind: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants Read SEC document |
| March 13, 2023 Filed Mar 29, 2023 16:55 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherWarrants to Purchase Common Stock · Derivative | 19,297 | $0.01 Strike: $6.30 | $192.97 |
DisclosureSEC source: 0001493152-23-009491 · ownership.xml · derivative · entry 12 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner Knight Insurance Company, Ltd · CIK 0001971547 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Knightbrook Insurance Company Disclosed balance after: 19,297 Underlying: Common · 19,297 shares Expires 2026-10-13 F1 · kind: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants Read SEC document |
| March 13, 2023 Filed Mar 29, 2023 16:55 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherWarrants to Purchase Common Stock · Derivative | 99,148 | $0.01 Strike: $6.30 | $991.48 |
DisclosureSEC source: 0001493152-23-009491 · ownership.xml · derivative · entry 11 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner Knight Insurance Company, Ltd · CIK 0001971547 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Knight Insurance Company, Ltd. Disclosed balance after: 99,148 Underlying: Common · 99,148 shares Expires 2026-10-13 F1 · kind: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants Read SEC document |
| March 13, 2023 Filed Mar 29, 2023 16:55 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherWarrants to Purchase Common Stock · Derivative | 5,252 | $0.01 Strike: $6.30 | $52.52 |
DisclosureSEC source: 0001493152-23-009491 · ownership.xml · derivative · entry 10 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner Knight Insurance Company, Ltd · CIK 0001971547 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Knight Services, Inc Disclosed balance after: 5,252 Underlying: Common · 5,252 shares Expires 2026-10-13 F1 · kind: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants Read SEC document |
| March 13, 2023 Filed Mar 29, 2023 16:55 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherWarrants to Purchase Common Stock · Derivative | 280,764 | $0.01 Strike: $6.30 | $2,807.64 |
DisclosureSEC source: 0001493152-23-009491 · ownership.xml · derivative · entry 9 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner Knight Insurance Company, Ltd · CIK 0001971547 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Don Hankey Trust Disclosed balance after: 280,764 Underlying: Common · 280,764 shares Expires 2026-10-13 F1 · kind: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants Read SEC document |
| March 13, 2023 Filed Mar 29, 2023 16:55 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherWarrants to Purchase Common Stock · Derivative | 33,811 | $0.01 Strike: $6.30 | $338.11 |
DisclosureSEC source: 0001493152-23-009491 · ownership.xml · derivative · entry 8 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner Knight Insurance Company, Ltd · CIK 0001971547 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Hankey Capital, LLC Disclosed balance after: 0 Underlying: Common · 33,811 shares Expires 2026-10-13 F1 · kind: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants Read SEC document |
| March 13, 2023 Filed Mar 29, 2023 16:55 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherCommon Stock | 500,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-009491 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner Knight Insurance Company, Ltd · CIK 0001971547 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 0 F1 · kind: On March 27, 2023, Hankey Capital LLC transferred an aggregate of 7,043,801 shares and 476,190 shares issuable upon exercise of warrants of the Company as follows: a. Don Hankey Trust, Related Party, 4,153,065 shares, 280,764 warrants b. Knight Services, Inc, Related Party, 77,681 shares, 5,252 warrants c. Knight Insurance Company, Ltd., Related Party, 1,466,603 shares, 99,148 warrants d. Knightbrook Insurance Company, Related Party, 285,438 shares, 19,297 warrants e. Knight Specialty Insurance Company, Related Party, 560,877 shares, 37,918 warrants f. Unrelated Parties, 500,137 shares, 33,811 warrants Read SEC document |
| October 15, 2021 Filed Oct 20, 2021 00:17 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherWarrants to Purchase Common Stock · Derivative | 476,190 | $0.01 Strike: $6.30 | $4,761.90 |
DisclosureSEC source: 0001493152-21-025816 · ownership.xml · derivative · entry 5 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 476,190 Underlying: Common · 476,190 shares Expires 2026-10-13 F3 · price: Represents shares purchased in the Issuer's public offering of units, with each unit consisting of one share of Common Stock and one Warrant. The allocation of a unit is $5.24 for a common share, and $0.01 for a warrant. Read SEC document |
| October 15, 2021 Filed Oct 20, 2021 00:17 UTC | Bone Biologics Corp BBLG · Entity 8560 | GiftCommon Stock | 1,004,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-025816 · ownership.xml · nonDerivative · entry 4 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · BY HANKEY CAPITAL, LLC Disclosed balance after: 7,025,802 F4 · kind: Represents shares gifted to third parties. Read SEC document |
| October 15, 2021 Filed Oct 20, 2021 00:17 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherCommon Stock | 476,190 | $5.24 | $2,495,235.60 |
DisclosureSEC source: 0001493152-21-025816 · ownership.xml · nonDerivative · entry 3 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · BY HANKEY CAPITAL, LLC Disclosed balance after: 8,030,112 F3 · kind: Represents shares purchased in the Issuer's public offering of units, with each unit consisting of one share of Common Stock and one Warrant. The allocation of a unit is $5.24 for a common share, and $0.01 for a warrant. Read SEC document |
| October 15, 2021 Filed Oct 20, 2021 00:17 UTC | Bone Biologics Corp BBLG · Entity 8560 | ConversionCommon Stock | 9,361,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-025816 · ownership.xml · nonDerivative · entry 2 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · BY HANKEY CAPITAL, LLC Disclosed balance after: 7,553,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents cancelation of collateral shares issued to secure the debt. Read SEC document |
| October 15, 2021 Filed Oct 20, 2021 00:17 UTC | Bone Biologics Corp BBLG · Entity 8560 | ConversionCommon Stock | 5,928,774 | $2.50 | $14,821,935.00 |
DisclosureSEC source: 0001493152-21-025816 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · BY HANKEY CAPITAL, LLC Disclosed balance after: 16,915,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares issued upon conversion of debt at a conversion rate of $2.50 per share. Read SEC document |
| January 02, 2020 Filed Jan 17, 2020 22:22 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 195,000 | $1.00 | $195,000.00 |
DisclosureSEC source: 0001493152-20-000773 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 28,563,398 F1 · shares: Consists of shares transferred from H&H Funding LLC ("H&H") to Hankey Capital LLC ("Hankey Capital"). Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey is the sole manager of H&H. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital and H&H except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 28,563,398 shares of the Company consisting of 4,062,870 shares owned by Hankey Capital, 23,404,255 Collateral Shares for which Hankey Capital has voting rights, 335,000 shares issuable to Hankey Capital upon conversion of debt, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 79,240 shares held by H&H Funding LLC and 320,393 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 17:46 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 553,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-011866 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 28,465,740 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 28,465,740 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 23,404,255 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 18:05 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 85,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-010727 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 27,912,549 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 27,912,549 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 22,851,064 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 19:39 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 1,063,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-009561 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: Not disclosed F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · valueOwnedAfter: Mr. Hankey is the beneficial owner of 27,827,443 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 22,765,958 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| May 07, 2019 Filed May 24, 2019 18:07 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 1,063,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-008227 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 26,763,613 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 26,763,613 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 21,702,128 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 19:28 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 1,489,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-003931 · ownership.xml · nonDerivative · entry 2 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 25,699,783 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 25,699,783 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 20,638,298 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| December 17, 2018 Filed Mar 26, 2019 19:28 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 18,009,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-003931 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 24,210,421 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.